Effects of imipenem-cilastatin sodium combined with immunoglobulin on serum PCT, hs-CRP and TNF-α in children with baby sepsis complicated with disseminated intravascular coagulation
10.12092/j.issn.1009-2501.2020.05.013
- VernacularTitle: 亚胺培南-西司他丁钠联合免疫球蛋白对婴儿脓毒症并发弥散性血管内凝血的疗效
- Author:
Caiwang RU
1
Author Information
1. Department of Neonatology, Children's Hospital Affiliated to Zhejiang University School of Medicine
- Publication Type:Journal Article
- Keywords:
Baby sepsis;
Disseminated intravascular coagulation;
Imipenem-cilastatin sodium;
Immunoglobulin;
Serum inflammatory factor
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2020;25(5):559-565
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To investigate the effects of imipenem-cilastatin sodium combined with immunoglobulin on serum PCT, hs-CRP and TNF-α in child with baby sepsis complicated with disseminated intravascular coagulation (DIC). METHODS: Ninty-two cases of patients with sepsis and DIC neonates admitted to our hospital from January 2013 to April 2019 were enrolled in this study. All the children were divided into observation group and control group according to random number table method, 46 cases in each group. The patients in the control group were treated with imipenem-cilastatin sodium, and the patients in the observation group were treated with imipenem-cilastatin sodium combined with immunoglobulin. The efficacy of the two groups, the time of DIC index returned to normal, bleeding stopped and ICU hospitalization time, coagulation parameters (FIB, PLT, D-D, TT), serum inflammatory factor levels and incidence of adverse reactions were compared. RESULTS: The total effective rate of treatment in the observation group was 93.48% (43/46), which was higher than that in the control group (78.26%, 36/46) (P<0.05). The DIC index of the observation group returned to normal time, bleeding stop time, ICU hospitalization time was shorter than those of the control group (P<0.05). After 5 days of treatment, the plasma levels of FIB, D-D and TT were decreased in the two groups, and the observation group was lower than those of the control group, the difference was statistically significant (P<0.05). After 5 days of treatment, the expressions of serum PCT, hs-CRP and TNF-α were decreased in the two groups, and the observation group was lower than the control group (P<0.05). There was no significant difference in the incidence of adverse drug reactions between the two groups [2.17% (1/46) vs. 6.52% (3/46)] (P>0.05). CONCLUSION: Imipenem-cilastatin combined with immunoglobulin is effective in the treatment of baby sepsis complicated with DIC. It can alleviate or eliminate bleeding and other symptoms, shorten ICU hospitalization time, improve coagulation function, and reduce serum PCT and hs-CRP, TNF-α expression, and the body's inflammatory response, combined with fewer adverse reactions, which has a higher clinical value.
